Figure 2.
Figure 2. Modeling of NFRKB mutations. NFRKB mutations (red lollipops) annotated on protein primary sequence with additional information regarding posttranslational modifications (PTMs) and domain composition. Three-dimensional structural model showing the deubiquitinating enzyme-binding domain (Protein Data Bank identifier [PDB ID]: 4UF5), the winged domain (PDB ID: 3U21), and the transcriptional regulation domain (by homology; PDB ID: 3BY6). The 2 stop-gain mutations R290* and K322* are predicted to delete the protein region responsible for mediating interactions with transcriptional regulators and/or DNA whereas leaving the N-terminal region deputed to the interaction with deubiquitnating enzymes. The R174C mutation is predicted to perturb adjacent phosphosites, for example, S176, and is located in a motif predicted by the Eukaryotic Linear Motif (ELM; elm.eu.org) to be either the phosphorylation site of GSK3 and MAPK or the docking site for USP7 or the Pin1 WW domain. The C-terminal deletion by Q1103* is predicted to have detrimental consequences, as it is rich in phosphorylation sites (eg, CK1 and GSK3) or recognition sites for FHA and WDR5.

Modeling of NFRKB mutations.NFRKB mutations (red lollipops) annotated on protein primary sequence with additional information regarding posttranslational modifications (PTMs) and domain composition. Three-dimensional structural model showing the deubiquitinating enzyme-binding domain (Protein Data Bank identifier [PDB ID]: 4UF5), the winged domain (PDB ID: 3U21), and the transcriptional regulation domain (by homology; PDB ID: 3BY6). The 2 stop-gain mutations R290* and K322* are predicted to delete the protein region responsible for mediating interactions with transcriptional regulators and/or DNA whereas leaving the N-terminal region deputed to the interaction with deubiquitnating enzymes. The R174C mutation is predicted to perturb adjacent phosphosites, for example, S176, and is located in a motif predicted by the Eukaryotic Linear Motif (ELM; elm.eu.org) to be either the phosphorylation site of GSK3 and MAPK or the docking site for USP7 or the Pin1 WW domain. The C-terminal deletion by Q1103* is predicted to have detrimental consequences, as it is rich in phosphorylation sites (eg, CK1 and GSK3) or recognition sites for FHA and WDR5.

Close Modal

or Create an Account

Close Modal
Close Modal